Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | GMI-1359 |
| Trade Name | |
| Synonyms | GMI1359|GMI 1359 |
| Drug Descriptions |
GMI-1359 is a dual inhibitor of Cxcr4 and E-selectin, which may inhibit leukemia cell adhesion and lead to apoptosis (Blood 2015 126(23):3790, PMID: 31877673, PMID: 31431613). |
| DrugClasses | CXCR4 Inhibitor 15 |
| CAS Registry Number | NA |
| NCIT ID | C167271 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| GMI-1359 | GMI-1359 | 1 | 1 |
| GMI-1359 + Sorafenib | GMI-1359 Sorafenib | 1 | 0 |